Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.310
+0.050 (2.21%)
Aug 19, 2026, 9:51 AM EDT - Market open

Pulmonx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
99912684883151,181
Market Cap Growth
56.08%-66.00%-45.11%54.88%-73.31%-52.01%
Enterprise Value
100712163911841,006
Last Close Price
2.262.216.7912.758.4332.07
PS Ratio
1.111.013.207.115.8824.40
PB Ratio
2.481.683.134.132.056.11
P/TBV Ratio
2.681.783.214.212.086.20
EV/Sales Ratio
1.110.792.585.693.4220.77
Debt / Equity Ratio
1.431.040.660.350.160.14
Net Debt / Equity Ratio
0.01-0.25-0.52-0.76-0.80-0.85
Net Debt / EBITDA Ratio
-0.010.250.831.492.153.54
Net Debt / FCF Ratio
-0.010.411.372.342.643.65
Asset Turnover
0.670.620.490.370.250.19
Inventory Turnover
1.231.431.301.150.890.95
Quick Ratio
3.364.114.725.628.1310.65
Current Ratio
4.325.075.586.509.1411.85
Return on Equity (ROE)
-88.87%-77.19%-55.25%-44.69%-33.94%-23.21%
Return on Assets (ROA)
-22.10%-22.96%-20.54%-20.84%-17.09%-11.85%
Return on Capital Employed (ROCE)
-49.10%-49.10%-40.40%-40.10%-33.50%-21.70%
Earnings Yield
-49.57%-59.24%-21.03%-12.46%-18.68%-4.12%
FCF Yield
-31.60%-36.01%-12.30%-7.87%-14.71%-3.81%
Buyback Yield / Dilution
-4.69%-4.03%-2.99%-2.37%-2.68%-254.74%
SEC Filings: 10-K · 10-Q